Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Vision Impairment Contributes to Dementia Risk
The population-attributable fraction of dementia from vision impairments ranges from 4.9 to 19.0 percent, according to a study published online Sept. 5 in JAMA
Abdominal Adipose Tissue Linked to Musculoskeletal Pain
For women and men, abdominal adipose tissue is associated with chronic musculoskeletal pain, according to a study published online Sept. 10 in Regional Anesthes
Preclinical Blood Test IDs Risk for Respiratory Death, Incident COPD
A proteomic signature indicating increased respiratory susceptibility identifies the risk for respiratory death, incident chronic obstructive pulmonary disease
Weekly Insulin Injections As Effective for Diabetes as Daily Shots, Studies Show
all while lowering A1C. These results can make a significant impact for people living with type 2 diabetes looking for a once-weekly option that provides simila
Good Maternity Care Increasingly Tough to Find in U.S.
a tragedy exacerbated by a lack of resources to care for them, let alone save them, Tatyana Ali, American actress ( Fresh Prince of Bel Air ) and March of Dimes
Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug
An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.People who took the drug amycretin lost up to 13 of their body wei
Weight-Loss Pill Saxenda Helps Kids as Young as 6
but when used alone, the effect is modest and, as yet, no medication is approved for the treatment of general obesity in children who are younger than 12. Lirag
FDA to Investigate Safety of Toxic Metals in Tampons
The U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects of toxic metals found in tampons.The
Dupixent Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria
TARRYTOWN, N.Y. and PARIS, Sept. 11, 2024. Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Dupixent (dupilumab) confirmatory Phase 3 trial (LI
First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA in mIDH1 AML
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2024. Rigel Pharmaceuticals, a commercial stage biotechnology company focused on hematologic disorders and cancer, today a
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions